Brian K. Link

Also affiliated with University of Iowa Hospitals and Clinics

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.1Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes

American Journal of Hematology(2024)10.1002/ajh.27202

Top 10%

2.1DataRank

Top 10%24 citations

Matthew J. Maurer, Brian K. Link, Andrew L. Feldman, Thomas M. Habermann, David L. Jaye +38 more

Papers

Driven by 41 papers — median percentile 90. Top paper: “Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma”.

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Journal of Clinical Oncology(2020)10.1200/jco.20.00303

N/A

5.0DataRank · unranked

152 citations

Kieron Dunleavy, Jeremy S. Abramson, Bayard L. Powell, Brian K. Link, Prapti A. Patel +19 more

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes

American Journal of Hematology(2024)10.1002/ajh.27202

Top 10%

2.1DataRank

Top 10%24 citations

Matthew J. Maurer, Brian K. Link, Andrew L. Feldman, Thomas M. Habermann, David L. Jaye +38 more

Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma

Blood Cancer Journal(2021)10.1038/s41408-021-00521-4

N/A

0.631DataRank · unranked

66 citations

Angelo Famà, Melissa C. Larson, Andrew L. Feldman, José C. Villasboas, Zhi-Zhang Yang +20 more

Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

Leukemia(2022)10.1038/s41375-022-01711-0

N/A

0.529DataRank · unranked

33 citations

Vijai Joseph, Yolanda Benavente, Nicola J. Camp, Alexandra Nieters, Zhaoming Wang +95 more

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients

Blood Cancer Journal(2020)10.1038/s41408-020-00382-3

N/A

0.520DataRank · unranked

31 citations

Kerstin Wenzl, Keenan T. Hartert, Michelle K. Manske, Vivekananda Sarangi, Matthew J. Maurer +10 more

Revised MALT‐IPI: A new predictive model that identifies high‐risk patients with extranodal marginal zone lymphoma

American Journal of Hematology(2022)10.1002/ajh.26715

N/A

0.494DataRank · unranked

26 citations

Isildinha M. Reis, Thomas M. Habermann, Brian K. Link, Catherine Thiéblemont, Annarita Conconi +7 more

Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐GemOx: A Multicenter Cohort Study

American Journal of Hematology(2025)10.1002/ajh.27630

N/A

0.409DataRank · unranked

10 citations

Jean L. Koff, Melissa C. Larson, Brad S. Kahl, Carla Casulo, Izidore S. Lossos +25 more

Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL

Blood Cancer Journal(2024)10.1038/s41408-024-01080-0

N/A

0.385DataRank · unranked

12 citations

Matthew E. Stokes, Joseph P. Novak, Allison M. Bock, Sana Khan, Melissa A. Hopper +25 more

Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101443

N/A

0.373DataRank · unranked

11 citations

Kerstin Wenzl, Melissa A. Hopper, Michelle K. Manske, Vivekananda Sarangi, Matthew J. Maurer +16 more

Genetically Determined Height and Risk of Non-hodgkin Lymphoma

Frontiers in Oncology(2020)10.3389/fonc.2019.01539

N/A

0.345DataRank · unranked

9 citations

Eleanor Kane, Zhaoming Wang, Orestis A. Panagiotou, Lauren R. Teras, Alain Monnereau +74 more

Comparison of Survivorship Care Guidelines for Patients With Lymphoma: Recommendations for Harmonization and Future Research Agenda

JCO Oncology Practice(2024)10.1200/op.24.00364

N/A

0.292DataRank · unranked

6 citations

Kerry J. Savage, Brian K. Link, John P. Leonard, Kara M. Kelly, Gita Thanarajasingam +7 more

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Blood(2024)10.1182/blood.2024025681

N/A

0.269DataRank · unranked

5 citations

Matthew J. Maurer, Thomas M. Habermann, Richard Burack, Jennifer R. Chapman, Jonathon B. Cohen +18 more

Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma

Nature Communications(2025)10.1038/s41467-025-64666-7

N/A

0.165DataRank · unranked

2 citations

Roshia Ali, Alyssa Bouska, Dylan T. Jochum, Meghana Kesireddy, Simeon Mahov +34 more

Transformation of marginal zone lymphoma to Hodgkin lymphoma

Blood Advances(2024)10.1182/bloodadvances.2024013434

N/A

0.165DataRank · unranked

2 citations

Juan Pablo Alderuccio, Côme Bommier, Thomas Habermann, Brian K. Link, James R. Cerhan +3 more

Therapy for patients with POD24 follicular lymphoma: Treatment patterns and outcomes from the Lymphoma Epidemiology of Outcomes (LEO) Consortium.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7573

N/A

0.104DataRank · unranked

1 citations

Melissa C. Larson, Jonathan R Day, Thomas M. Habermann, Izidore S. Lossos, Yucai Wang +15 more

Prognostic relevance of CD4+ T-cells in the microenvironment of newly diagnosed follicular lymphoma (FL) patients is independent of the tumor gene expression profile.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8052

N/A

0.104DataRank · unranked

1 citations

Angelo Famà, Melissa C. Larson, Andew L. Feldman, Zhi-Zhang Yang, José C. Villasboas +13 more

Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

UNC Libraries(2024)10.17615/1b8m-w521

N/A

0DataRank · unranked

0 citations

Heather J. Sutherland, Paul Brennan, Laurie Burdett, Nicola J. Camp, Xiaosheng Wu +95 more

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

UNC Libraries(2024)10.17615/vsck-8v23

N/A

0DataRank · unranked

0 citations

N. Chatterjee, A. Maria, Lynn R. Goldin, Vijai Joseph, Sílvia de Sanjosé +76 more

Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes

UNC Libraries(2024)10.17615/e1wv-7413

N/A

0DataRank · unranked

0 citations

Sílvia de Sanjosé, Ruth C. Travis, Paul Brennan, Michael Dean, Weiyin Zhou +77 more

Transformation of marginal zone lymphoma to Hodgkin lymphoma

UNC Libraries(2024)10.17615/qw81-3587

N/A

0DataRank · unranked

0 citations

Juan Pablo Alderuccio, James R. Cerhan, Kamilia Moalem, Brian K. Link, Izidore S. Lossos +3 more

Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01326-5

N/A

0DataRank · unranked

7 citations

Kerstin Wenzl, Joseph P. Novak, Matthew E. Stokes, Melissa A. Hopper, Abigail R. Dropik +17 more

Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop

Blood Advances(2025)10.1182/bloodadvances.2025018079

N/A

0DataRank · unranked

3 citations

Sarah C. Rutherford, Stephen M. Ansell, Philippe Armand, John P. Leonard, Loretta J. Nastoupil +20 more

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma

Journal of Clinical Oncology(2025)10.1200/jco-25-00892

N/A

0DataRank · unranked

1 citations

Vít Procházka, Tarec Christoffer El‐Galaly, Christopher R. Flowers, Diego Villa, Emmanuel Bachy +43 more

29 | A COMPARATIVE ANALYSIS OF HISTOLOGIC TRANSFORMATION OF FOLLICULAR LYMPHOMA AT DIAGNOSIS (COMPOSITE LYMPHOMA) AND SEQUENTIALLY TRANSFORMED FOLLICULAR LYMPHOMA

Hematological Oncology(2025)10.1002/hon.70093_29

N/A

0DataRank · unranked

0 citations

Melissa C. Larson, Jonathan Day, Urshila Durani, Mazie Tsang, Dai Chihara +22 more

233 | S1608: RANDOMIZED PHASE II TRIAL COMPARING LENALIDOMIDE/OBINUTUZUMAB AND UMBRALISIB/OBINUTUZUMAB WITH CHEMOIMMUNOTHERAPY IN EARLY PROGRESSING FOLLICULAR LYMPHOMA (POD24)

Hematological Oncology(2025)10.1002/hon.70094_233

N/A

0DataRank · unranked

0 citations

H. Li, Heiko Schöder, Alex F. Herrera, Richard Burack, Brian K. Link +10 more

Genetically determined body mass index is associated with diffuse large B‐cell lymphoma in polygenic and Mendelian randomization analyses

International Journal of Cancer(2025)10.1002/ijc.70039

N/A

0DataRank · unranked

0 citations

Eleanor Kane, Lauren R. Teras, Mitchell J. Machiela, Joshua Arias, Orestis A. Panagiotou +70 more

A genome-wide association study of marginal zone lymphoma shows association to the HLA region

UNC Libraries(2020)10.17615/jztp-9s41

N/A

0DataRank · unranked

0 citations

Nikolaus Becker, Bengt Glimelius, Jian Gu, Brenda M. Birmann, Kari E. North +27 more

Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia

UNC Libraries(2020)10.17615/2qt3-6p69

N/A

0DataRank · unranked

0 citations

Moara Machado, Cristine Allmer, Yolanda Benavente, Jennifer Turner, John J. Spinelli +95 more

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

UNC Libraries(2020)10.17615/y5gv-3561

N/A

0DataRank · unranked

0 citations

Anneclaire J. De Roos, Brian K. Link, Anne J. Novak, Yuanqing Ye, Mitchell J. Machiela +95 more

Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region

WOS(2020)10.17615/8581-7w55

N/A

0DataRank · unranked

0 citations

Sonja I. Berndt, Meredith Yeager, Gilles Salles, Anne Kricker, Lindsay M. Morton +27 more

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

UNC Libraries(2020)10.17615/jtnt-qj24

N/A

0DataRank · unranked

0 citations

Robert J. Harris, Paolo Boffetta, Sílvia de Sanjosé, Guillem Clot, Larry Mansouri +92 more

Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes

Journal of Translational Genetics and Genomics(2021)10.20517/jtgg.2021.08

N/A

0DataRank · unranked

0 citations

Mitchell J. Machiela, Moara Machado, Sophia Wang, Eleanor Kane, Susan L. Slager +77 more

Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study

The Lancet Haematology(2022)10.1016/s2352-3026(22)00033-3

N/A

0DataRank · unranked

64 citations

Melissa C. Larson, Julianne J. Lunde, Thomas M. Habermann, Izidore S. Lossos, Yucai Wang +19 more

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2022009225

N/A

0DataRank · unranked

11 citations

Jeffrey M. Switchenko, Veronika Bachanová, James N. Gerson, Stefan K. Barta, Max J. Gordon +30 more

Preliminary results from an early phase trial of in situ immunization of lymphoma with a virus likeparticle containing a TLR9 agonist combined with anti-PD1 therapy (NCT03983668).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2639

N/A

0DataRank · unranked

0 citations

Sabarish Ayyappan, Chaobo Yin, Caitlin D. Lemke, Brian J. Smith, Brian K. Link +2 more

Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study

Blood Cancer Journal(2023)10.1038/s41408-023-00942-3

N/A

0DataRank · unranked

9 citations

Jennifer Gile, Melissa C. Larson, Kittika Poonsombudlert, Reema Tawfiq, Seth Maliske +14 more

Molecular classification and identification of an aggressive signature in low‐grade B‐cell lymphomas

Hematological Oncology(2023)10.1002/hon.3187

N/A

0DataRank · unranked

5 citations

Kerstin Wenzl, Keenan T. Hartert, Jordan E. Krull, Abigail R. Dropik, Joseph P. Novak +16 more

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

Blood Advances(2023)10.1182/bloodadvances.2023010223

N/A

0DataRank · unranked

0 citations

Kieron Dunleavy, Jeremy S. Abramson, Brian K. Link, Bayard L. Powell, Christopher Melani +10 more

Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation

Nature Communications(2024)10.1038/s41467-024-50830-y

N/A

0DataRank · unranked

17 citations

Kerstin Wenzl, C. Chris Huang, María Ortiz, Chih-Chao Hsu, Matthew J. Maurer +23 more

Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102592

N/A

0DataRank · unranked

14 citations

Côme Bommier, Juan Pablo Alderuccio, Michele Merli, Nicole Fabbri, Maria Elena Nizzoli +30 more

DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas

Blood Cancer Journal(2024)10.1038/s41408-024-01145-0

N/A

0DataRank · unranked

4 citations

Abigail R. Dropik, Janek S. Walker, Joseph P. Novak, M. Laverty, Michelle K. Manske +16 more

Brian K. Link

Indexed papers

Top data-sharing exemplar

Papers